Toggle light / dark theme

Some fear that expensive rejuvenation treatments would give rise to discrimination, but what about the discrimination against old people resulting from not developing rejuvenation?


It’s been quite a while since I posted anything new. I’ve been quite busy lately with a lot of things, including rebooting looking4troubles, my other blog. As a result, my topic list for Rejuvenaction has been growing dangerously long, so I decided it’s about time I tackled some of the lengthiest items on my list.

People like talking about justice, equality, and discrimination a lot. I mean a lot. In my experience, though, most tend to focus mainly or entirely on the type(s) of discrimination they’re more interested in for whatever reason, sometimes minimising others or not even noticing they exist in the first place. Some other times, they even end up endorsing one type of discrimination for the sake of warding off another.

As if poor people cared

Take the good ol’ ‘only the rich ‘ objection against rejuvenation. Its essence is that, to forestall the possibility of rejuvenation being available only to a few wealthy ones, rejuvenation should not be created at all—if not everyone can have it, then no one should have it.

Read more

Researchers have developed a line immortal stem cells that allow them to generate an unlimited supply of artificial red blood cells on demand.

If these artificial blood cells pass clinical trials, they’ll be far more efficient for medical use than current red blood cell products, which have to be generated from donor blood — and would be a huge deal for patients with rare blood types, who often struggle to find matching blood donors.

The idea isn’t for these immortal stem cells to replace blood donation altogether — when it comes to regular blood transfusions, donated blood still does the trick.

Read more

An exclusive interview with Ichor, the biotech company pioneering a SENS based repair therapy that could help cure age related blindness.


Check out our exclusive interview with Ichor the company taking the first SENS based therapy to the clinic. Should clinical trials be a success this will mark the arrival of a technology that addresses one of the aging processes.

Read more

Is the risk of cultural stagnation a valid objection to rejuvenation therapies? You guessed it—nope.


This objection can be discussed from both a moral and a practical point of view. This article discusses the matter from a moral standpoint, and concludes it is a morally unacceptable objection. (Bummer, now I’ve spoiled it all for you.)

However, even if the objection can be dismissed on moral grounds, one may still argue that, hey, it may be immoral to let old people die to avoid cultural and social stagnation, but it’s still necessary.

One could argue that. But one would be wrong.

Read more

Newyorker article about aging research. At least they gave both the conservative and more progressive camps a mention though it appears the author sides with the healthspan crowd.


A large article in the newyorker about longevity research. The conservative and the more radical approaches are discussed including SENS.

Amusing to note that the mainstream are portrayed as healthspanners and dont think its possible to comprehensively fix aging. Looks like we have much work to do to change that view.

Read more